Clinical Trials Browser

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Phase 4 Active not recruiting

134 enrolled

Breast

Breast Neoplasms

NCT05252585 2026-04-02

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Phase 4 Active not recruiting

4 enrolled

Tuberous Sclerosis, Angiomyolipoma

NCT01742299 2026-04-01

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Phase 4 Active not recruiting

155 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05160922 2026-03-30

Crizotinib Continuation Clinical Study

Phase 4 Active not recruiting

27 enrolled

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT04033081 2026-03-23

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

Phase 4 Active not recruiting

100 enrolled

Sarcoma

NCT03173092 2026-03-18

A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

Phase 4 Active not recruiting

141 enrolled

Plasma cell

Multiple Myeloma

NCT02386800 2026-03-16

CINC424A2X01B Rollover Protocol

Phase 4 Active not recruiting

279 enrolled

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

NCT05864846 2026-03-12

EpiCom

Phase 4 Active not recruiting

79 enrolled

Behavior, Seizures, Tuberous Sclerosis

NCT06752850 2025-12-19

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Phase 4 Active not recruiting

37 enrolled

Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular, Synovitis

NCT05144997 2025-12-17

Lorlatinib Continuation Study

Phase 4 Active not recruiting

76 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03229200 2025-10-30

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Phase 4 Active not recruiting

297 enrolled

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell

NCT04586660 2025-10-01

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Phase 4 Active not recruiting

36 enrolled

Giant Cell Tumor of Bone

NCT06285370 2025-09-18

A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy

Phase 4 Active not recruiting

23 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT06074510 2025-09-11

MIRROR

Phase 4 Active not recruiting

274 enrolled

Genitourinary

Prostatic Neoplasms

NCT05342883 2025-09-05

GESTALT

Phase 4 Active not recruiting

61 enrolled

CNS

Glioblastoma, Glioma, Neoplasms

NCT01896479 2025-09-02

EXAMINER

Phase 4 Active not recruiting

247 enrolled 14 charts

Head & Neck

Thyroid Neoplasms, Carcinoma, Medullary

NCT05486182 2025-08-14

ESTROTIMP

Phase 4 Active not recruiting

153 enrolled

Breast

Breast Neoplasms

NCT05144243 2025-08-12

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Phase 4 Active not recruiting

44 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05387525 2025-02-11

AKtive

Phase 4 Active not recruiting

447 enrolled

Dermatologic

Keratosis, Actinic